We represented Consonance Capital Partners, a leading healthcare-focused private equity fund, in the recapitalization of Orsini Pharmaceutical Services, LLC, in partnership with the Company’s CEO and President, Michael Fieri.

Orsini is a leading rare disease specialty pharmacy differentiated by its personalized service and focus on complex conditions that require a high-touch patient journey. Financial terms of the transaction were not disclosed.